IE 11 is not supported. For an optimal experience visit our site on another browser.

OraSure Technologies to Participate at the UBS Global Life Sciences Conference

/ Source: GlobeNewswire

BETHLEHEM, Pa., Sept. 14, 2010 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the UBS Global Life Sciences Conference in New York City at approximately 4:00pm Eastern Time, (1:00pm Pacific Time) on Monday, September 20, 2010. The conference will be simultaneously webcast over the Internet.

Interested investors can access the live audio webcast of the discussion by going to OraSure Technologies' web site, , and clicking on the Investor Information link. A replay of the audio webcast will be available until September 27, 2010, on OraSure Technologies' web site.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.

For more information on the Company, please go to .

The OraSure Technologies, Inc. logo is available at

CONTACT: OraSure Technologies, Inc. Ronald H. Spair, Chief Financial Officer 610-882-1820 Investorinfo@orasure.com www.orasure.com